We are live on ! Find out more
NBTX icon

Nanobiotix
NBTX

10 hedge funds and large institutions have $73.2M invested in Nanobiotix in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.17% less ownership

Funds ownership: 14.15% → 13.98% (-0.17%)

9% less funds holding

Funds holding: 11 → 10 (-1)

45% less capital inflows, than outflows

Capital inflows: $1.2M | Capital outflows: $2.19M

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
10
Holders Change
-1
Holders Change %
-9.09%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$1.2M

Top Sellers

Rank Fund Capital Flow
1
Perceptive Advisors
Perceptive Advisors
New York
-$691K
2
Citadel Advisors
Citadel Advisors
Florida
-$537K
3
Millennium Management
Millennium Management
New York
-$433K
4
MIM
Monashee Investment Management
Massachusetts
-$248K
5
Morgan Stanley
Morgan Stanley
New York
-$192K

NBTX Hedge Fund Activity: Q1 2021 in Review

10 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Nanobiotix (NBTX) for Q1 2021, worth a combined $73.2M — down 10% from $81.3M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of NBTX and 1 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $1.2M. The largest seller was Perceptive Advisors, cutting an estimated $691K.

  • 10 institutional investors held Nanobiotix (NBTX) as of Q1 2021, down from 11 in Q4 2020.
  • Funds reported $73.2M of Nanobiotix stock for Q1 2021, down 10% quarter-over-quarter.
  • 1 fund opened new Nanobiotix positions in Q1 2021 and 2 closed out, a net change of -1 holder.
  • The largest Nanobiotix buyer in Q1 2021 was UBS Group, an estimated $1.2M added.
  • The largest Nanobiotix seller in Q1 2021 was Perceptive Advisors, an estimated $691K sold.

Based on aggregated 13F filings for Q1 2021.